This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, K. L.
Right arrow Articles by Kieff, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, K. L.
Right arrow Articles by Kieff, E.

 Previous Article  |  Next Article 

Journal of Virology, October 2002, p. 10427-10436, Vol. 76, No. 20
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.20.10427-10436.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression

Kara L. Carter,{dagger} Ellen Cahir-McFarland, and Elliott Kieff*

Departments of Medicine and Microbiology and Molecular Genetics, Harvard Medical School, and The Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115

Received 14 February 2002/ Accepted 15 July 2002

To elucidate the mechanisms by which Epstein-Barr virus (EBV) latency III gene expression transforms primary B lymphocytes to lymphoblastoid cell lines (LCLs), the associated alterations in cell gene expression were assessed by using 4,146 cellular cDNAs arrayed on nitrocellulose filters and real-time reverse transcription-PCR (RT-PCR). A total of 1,405 of the 4,146 cDNAs were detected using cDNA probes from poly(A)+ RNA of IB4 LCLs, a non-EBV-infected Burkitt's lymphoma (BL) cell line, BL41, or EBV latency III-converted BL41 cells (BL41EBV). Thirty-eight RNAs were consistently twofold more abundant in the IB4 LCL and BL41EBV than in BL41 by microarray analysis. Ten of these are known to be EBV induced. A total of 23 of 28 newly identified EBV-induced genes were confirmed by real-time RT-PCR. In addition, nine newly identified genes and CD10 were EBV repressed. These EBV-regulated genes encode proteins involved in signal transduction, transcription, protein biosynthesis and degradation, and cell motility, shape, or adhesion. Seven of seven newly identified EBV-induced RNAs were more abundant in newly established LCLs than in resting B lymphocytes. Surveys of eight promoters of newly identified genes implicate NF-{kappa}B or PU.1 as potentially important mediators of EBV-induced effects through LMP1 or EBNA2, respectively. Thus, examination of the transcriptional effects of EBV infection can elucidate the molecular mechanisms by which EBV latency III alters B lymphocytes.

* Corresponding author. Mailing address: The Channing Laboratory, Brigham and Women's Hospital, 181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-4252. Fax: (617) 525-4257. E-mail: ekieff{at}rics.bwh.harvard.edu.

{dagger} Present address: Praecis Pharmaceuticals Incorporated, Waltham, MA 02451.

Journal of Virology, October 2002, p. 10427-10436, Vol. 76, No. 20
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.20.10427-10436.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zhang, W., Zeng, Z., Zhou, Y., Xiong, W., Fan, S., Xiao, L., Huang, D., Li, Z., Li, D., Wu, M., Li, X., Shen, S., Wang, R., Cao, L., Tang, K., Li, G. (2009). Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin 41: 414-428 [Abstract] [Full Text]  
  • Klibi, J., Niki, T., Riedel, A., Pioche-Durieu, C., Souquere, S., Rubinstein, E., Moulec, S. L. E., Guigay, J., Hirashima, M., Guemira, F., Adhikary, D., Mautner, J., Busson, P. (2009). Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113: 1957-1966 [Abstract] [Full Text]  
  • Xu, D., Zhao, L., Del Valle, L., Miklossy, J., Zhang, L. (2008). Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes. J. Virol. 82: 6251-6258 [Abstract] [Full Text]  
  • Xing, L., Kieff, E. (2007). Epstein-Barr Virus BHRF1 Micro- and Stable RNAs during Latency III and after Induction of Replication. J. Virol. 81: 9967-9975 [Abstract] [Full Text]  
  • Pegtel, D. M., Subramanian, A., Meritt, D., Tsai, C.-H., Sheen, T.-S., Golub, T. R., Thorley-Lawson, D. A. (2007). IFN-{alpha}-Stimulated Genes and Epstein-Barr Virus Gene Expression Distinguish WHO Type II and III Nasopharyngeal Carcinomas. Cancer Res. 67: 474-481 [Abstract] [Full Text]  
  • Dinarello, C A, Kim, S-H (2006). IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 65: iii61-iii64 [Abstract] [Full Text]  
  • Maier, S., Staffler, G., Hartmann, A., Hock, J., Henning, K., Grabusic, K., Mailhammer, R., Hoffmann, R., Wilmanns, M., Lang, R., Mages, J., Kempkes, B. (2006). Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2. J. Virol. 80: 9761-9771 [Abstract] [Full Text]  
  • Xu, D., Brumm, K., Zhang, L. (2006). The Latent Membrane Protein 1 of Epstein-Barr Virus (EBV) Primes EBV Latency Cells for Type I Interferon Production. J. Biol. Chem. 281: 9163-9169 [Abstract] [Full Text]  
  • Zhao, B., Maruo, S., Cooper, A., R. Chase, M., Johannsen, E., Kieff, E., Cahir-McFarland, E. (2006). RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 103: 1900-1905 [Abstract] [Full Text]  
  • Goda, C., Kanaji, T., Kanaji, S., Tanaka, G., Arima, K., Ohno, S., Izuhara, K. (2006). Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 18: 233-240 [Abstract] [Full Text]  
  • Lua, D. T., Yasuike, M., Hirono, I., Aoki, T. (2005). Transcription Program of Red Sea Bream Iridovirus as Revealed by DNA Microarrays. J. Virol. 79: 15151-15164 [Abstract] [Full Text]  
  • Zhang, J., Wang, J., Wood, C., Xu, D., Zhang, L. (2005). Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Replication and Transcription Activator Regulates Viral and Cellular Genes via Interferon-Stimulated Response Elements. J. Virol. 79: 5640-5652 [Abstract] [Full Text]  
  • Najjar, I., Baran-Marszak, F., Le Clorennec, C., Laguillier, C., Schischmanoff, O., Youlyouz-Marfak, I., Schlee, M., Bornkamm, G. W., Raphael, M., Feuillard, J., Fagard, R. (2005). Latent Membrane Protein 1 Regulates STAT1 through NF-{kappa}B-Dependent Interferon Secretion in Epstein-Barr Virus-Immortalized B Cells. J. Virol. 79: 4936-4943 [Abstract] [Full Text]  
  • Zhang, J., Das, S. C., Kotalik, C., Pattnaik, A. K., Zhang, L. (2004). The Latent Membrane Protein 1 of Epstein-Barr Virus Establishes an Antiviral State via Induction of Interferon-stimulated Genes. J. Biol. Chem. 279: 46335-46342 [Abstract] [Full Text]  
  • Rieger, K. E., Chu, G. (2004). Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Res 32: 4786-4803 [Abstract] [Full Text]  
  • Cahir-McFarland, E. D., Carter, K., Rosenwald, A., Giltnane, J. M., Henrickson, S. E., Staudt, L. M., Kieff, E. (2004). Role of NF-{kappa}B in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells. J. Virol. 78: 4108-4119 [Abstract] [Full Text]  
  • DeBiasi, R. L., Clarke, P., Meintzer, S., Jotte, R., Kleinschmidt-Demasters, B. K., Johnson, G. L., Tyler, K. L. (2003). Reovirus-Induced Alteration in Expression of Apoptosis and DNA Repair Genes with Potential Roles in Viral Pathogenesis. J. Virol. 77: 8934-8947 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»